geneXplain

Upstream analysis

Discover unanticipated causal relationships in your data with our unique upstream analysis.

The geneXplain platform

A versatile online toolbox for bioinformatics, systems biology and cheminformatics

TRANSFAC

The Gold Standard: more than 6500 positional weight matrices, and more than 30 million sites from high-throughput approaches!

Cheminformatics

Predict activity spectra of substances, and exploredrug-drug interactions and relationships between biological activities with PASS, GUSAR and PharmaExpert.

Precision medicine

Keeping our key goal on drug target identification, our analysis methods allow finding of currently activated targets in the examined patient data and selection of the best fit therapy for every studied case.

Learn more

Coming soon!

Several days left before the Genome Enhancer official release on 1st of September 2019!

Genome Enhancer is a fully automated pipeline for patient’s multi-omics data analysis. It generates a comprehensive report about the personalized drug targets identified for a certain patient, or a group of patients, and the drugs that may be effective in this case. Genome Enhancer is using TRANSFAC®, TRANSPATH® and HumanPSD™ databases for the performed analysis. Learn more about Genome Enhancer.

Bioinformatics

Integrated promoter and pathway (“upstream”) analysis lays at the core of our approach to analyzing changes in gene or protein signatures in a cell as a consequence, for example, of disease pathogenesis. To reveal the full power of the platform and the upstream analysis, we recommend to apply it together with the databases TRANSFAC^® and TRANSPATH^®.

Learn more
The geneXplain platform is designed to ease the life of the bioinformatics expert who is in charge to evaluate experimental high-throughput data, but also effectively supports the experimental researcher to interpret his/her valuable data with an intuitive user interface. You are cordially invited to learn more about the geneXplain platform.

Learn more
The gold standard in the field of transcriptional regulation. This database comprises a unique collection of information about transcription factors (TFs), their genomic binding sites and binding site models (positional weight matrices), suitable for search for new TF binding sites. Learn more about the TRANSFAC database.

Systems biology

It is our wish to contribute to state of the art systems biological research by offering a comprehensive view of molecular and genetic networks operating in and constituting human cells.

Learn more
In addition to the TRANSPATH database (see above), we make available the world’s largest collection of interactions and pathways, the GeneWays database, through our geneXplain platform.

Learn more
The Human Proteome Survey Database (HumanPSD) is a rich compendium of human, mouse and rat proteins, their disease associations, biomarker properties and drug associations.

Learn more
The most comprehensive information repository on enzymes and enzyme ligand data. BRENDA is an indispensable resource when working with metabolic networks.

Cheminformatics

As soon as a potential target has been identified, for instance with our proprietary upstream analysis approach, the next question will be about drugs that may bind to that target. To adress this and related problems, we incorporated several stand-alone cheminformatics tools in our product range.

Learn more
Based on the world’s largest data collections pertaining to the biological activities of chemical compounds and their structures, PASS and PharmaExpert enable users to identify potential lead structures out of millions of chemical substances, thereby efficiently shortening development times for specific drugs or molecular probes for research purposes.

Learn more
PharmaExpert analyzes the relationships between biological activities, drug-drug interactions and multiple targeting of chemical compounds and selects compounds that have a pre-defined biological activity. It helps answer a question like “How to select the most promising compounds among those known to interact with the selected protein?

Learn more
Particularly valuable for experts is the program GUSAR, which enables construction of highly specific models based on own data sets.

News

Find history in our archive.

July 5, 2019

GeneXplain announces the major 5.0 release of the geneXplain platform.

List of all features

May 6, 2019

GeneXplain announces:

TRANSFAC^® 2019.2
TRANSPATH^® 2019.2
HumanPSD^TM 2019.2

April 18, 2019

GeneXplain’s concept of walking pathways developed by our CSO Alexander Kel lead to the identification of validated blood biomarkers for early detection of colorectal cancer (CRC).
Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
Read the full paper here.

March 11-13, 2019

GeneXplain will be represented at the 26th Molecular Medicine Conference (San Francisco, California), TRI-CON. We look forward to seeing you at the conference booth 333.

Conference link

March 6-9, 2019

GeneXplain participated in the kick-off meeting of PD-MitoQUANT in Dublin at RCSI.

Press release

Webpage PD-MitoQUANT